539 related articles for article (PubMed ID: 25980425)
1. Inactivated and subunit vaccines against porcine reproductive and respiratory syndrome: Current status and future direction.
Renukaradhya GJ; Meng XJ; Calvert JG; Roof M; Lager KM
Vaccine; 2015 Jun; 33(27):3065-72. PubMed ID: 25980425
[TBL] [Abstract][Full Text] [Related]
2. Live porcine reproductive and respiratory syndrome virus vaccines: Current status and future direction.
Renukaradhya GJ; Meng XJ; Calvert JG; Roof M; Lager KM
Vaccine; 2015 Aug; 33(33):4069-80. PubMed ID: 26148878
[TBL] [Abstract][Full Text] [Related]
3. Novel strategies and approaches to develop the next generation of vaccines against porcine reproductive and respiratory syndrome virus (PRRSV).
Huang YW; Meng XJ
Virus Res; 2010 Dec; 154(1-2):141-9. PubMed ID: 20655962
[TBL] [Abstract][Full Text] [Related]
4. Recombinant Porcine Reproductive and Respiratory Syndrome Virus Expressing Membrane-Bound Interleukin-15 as an Immunomodulatory Adjuvant Enhances NK and γδ T Cell Responses and Confers Heterologous Protection.
Cao QM; Ni YY; Cao D; Tian D; Yugo DM; Heffron CL; Overend C; Subramaniam S; Rogers AJ; Catanzaro N; LeRoith T; Roberts PC; Meng XJ
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643245
[TBL] [Abstract][Full Text] [Related]
5. Plasmid containing CpG oligodeoxynucleotides can augment the immune responses of pigs immunized with porcine reproductive and respiratory syndrome killed virus vaccine.
Quan Z; Qin ZG; Zhen W; Feng XZ; Hong J; Fei ZH
Vet Immunol Immunopathol; 2010 Aug; 136(3-4):257-64. PubMed ID: 20394988
[TBL] [Abstract][Full Text] [Related]
6. Porcine reproductive and respiratory syndrome (PRRS) virus-specific interferon-gamma(+) T-cell responses after PRRS virus infection or vaccination with an inactivated PRRS vaccine.
Piras F; Bollard S; Laval F; Joisel F; Reynaud G; Charreyre C; Andreoni C; Juillard V
Viral Immunol; 2005; 18(2):381-9. PubMed ID: 16035950
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges.
Geldhof MF; Vanhee M; Van Breedam W; Van Doorsselaere J; Karniychuk UU; Nauwynck HJ
BMC Vet Res; 2012 Oct; 8():182. PubMed ID: 23031319
[TBL] [Abstract][Full Text] [Related]
8. Development of a porcine reproductive and respiratory syndrome virus-like-particle-based vaccine and evaluation of its immunogenicity in pigs.
Binjawadagi B; Lakshmanappa YS; Longchao Z; Dhakal S; Hiremath J; Ouyang K; Shyu DL; Arcos J; Pengcheng S; Gilbertie A; Zuckermann F; Torrelles JB; Jackwood D; Fang Y; Renukaradhya GJ
Arch Virol; 2016 Jun; 161(6):1579-89. PubMed ID: 27008569
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cell-targeted porcine reproductive and respiratory syndrome virus (PRRSV) antigens adjuvanted with polyinosinic-polycytidylic acid (poly (I:C)) induced non-protective immune responses against heterologous type 2 PRRSV challenge in pigs.
Subramaniam S; Piñeyro P; Derscheid RJ; Madson DM; Magstadt DR; Meng XJ
Vet Immunol Immunopathol; 2017 Aug; 190():18-25. PubMed ID: 28778318
[TBL] [Abstract][Full Text] [Related]
10. Positive inductive effect of swine interleukin-4 on immune responses elicited by modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine.
Peng J; Wang J; Wu J; Du Y; Li J; Guo Z; Yu J; Xu S; Zhang Y; Sun W; Cong X; Shi J
Viral Immunol; 2013 Dec; 26(6):404-14. PubMed ID: 24328935
[TBL] [Abstract][Full Text] [Related]
11. Mucosal vaccines to prevent porcine reproductive and respiratory syndrome: a new perspective.
Renukaradhya GJ; Dwivedi V; Manickam C; Binjawadagi B; Benfield D
Anim Health Res Rev; 2012 Jun; 13(1):21-37. PubMed ID: 22717576
[TBL] [Abstract][Full Text] [Related]
12. A porcine reproductive and respiratory syndrome virus (PRRSV)-specific IgM as a novel adjuvant for an inactivated PRRSV vaccine improves protection efficiency and enhances cell-mediated immunity against heterologous PRRSV challenge.
Chen R; Liu B; Zhang X; Qin M; Dong J; Gu G; Wu C; Wang J; Nan Y
Vet Res; 2022 Aug; 53(1):65. PubMed ID: 35986391
[TBL] [Abstract][Full Text] [Related]
13. Porcine reproductive and respiratory syndrome virus vaccines: current status and strategies to a universal vaccine.
Hu J; Zhang C
Transbound Emerg Dis; 2014 Apr; 61(2):109-20. PubMed ID: 23343057
[TBL] [Abstract][Full Text] [Related]
14. Protective immunity induced by a recombinant pseudorabies virus expressing the GP5 of porcine reproductive and respiratory syndrome virus in piglets.
Qiu HJ; Tian ZJ; Tong GZ; Zhou YJ; Ni JQ; Luo YZ; Cai XH
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):309-19. PubMed ID: 15963827
[TBL] [Abstract][Full Text] [Related]
15. A Synthetic Porcine Reproductive and Respiratory Syndrome Virus Strain Confers Unprecedented Levels of Heterologous Protection.
Vu HL; Ma F; Laegreid WW; Pattnaik AK; Steffen D; Doster AR; Osorio FA
J Virol; 2015 Dec; 89(23):12070-83. PubMed ID: 26401031
[TBL] [Abstract][Full Text] [Related]
16. Efficacy evaluation of two commercial modified-live virus vaccines against a novel recombinant type 2 porcine reproductive and respiratory syndrome virus.
Sun YF; Zhou L; Bian T; Tian XX; Ren WK; Lu C; Zhang L; Li XL; Cui MS; Yang HC; Yu H
Vet Microbiol; 2018 Mar; 216():176-182. PubMed ID: 29519513
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a 20year old porcine reproductive and respiratory syndrome (PRRS) modified live vaccine (Ingelvac(®) PRRS MLV) against two recent type 2 PRRS virus isolates in South Korea.
Jeong J; Choi K; Kang I; Park C; Chae C
Vet Microbiol; 2016 Aug; 192():102-109. PubMed ID: 27527771
[TBL] [Abstract][Full Text] [Related]
18. Efficacy evaluation of three modified-live virus vaccines against a strain of porcine reproductive and respiratory syndrome virus NADC30-like.
Zhou L; Yang B; Xu L; Jin H; Ge X; Guo X; Han J; Yang H
Vet Microbiol; 2017 Aug; 207():108-116. PubMed ID: 28757009
[TBL] [Abstract][Full Text] [Related]
19. Impact of a novel inactivated PRRS virus vaccine on virus replication and virus-induced pathology in fetal implantation sites and fetuses upon challenge.
Karniychuk UU; Saha D; Vanhee M; Geldhof M; Cornillie P; Caij AB; De Regge N; Nauwynck HJ
Theriogenology; 2012 Oct; 78(7):1527-37. PubMed ID: 22980086
[TBL] [Abstract][Full Text] [Related]
20. Synthetic B- and T-cell epitope peptides of porcine reproductive and respiratory syndrome virus with Gp96 as adjuvant induced humoral and cell-mediated immunity.
Chen C; Li J; Bi Y; Yang L; Meng S; Zhou Y; Jia X; Meng S; Sun L; Liu W
Vaccine; 2013 Apr; 31(14):1838-47. PubMed ID: 23395588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
